arrow
A

Ana Faria

Universidade Nova de Lisboa
H指数:40
被引数:5,594

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Postprandial metabolic responses to a glycomacropeptide-based protein substitute in different meal contexts – Implications for phenylketonuria (PKU)

基于糖巨肽的蛋白质替代品在不同餐食背景下的餐后代谢反应——对苯丙酮尿症(PKU)的启示

2026-08-060
OA
Protein substitutes used in the treatment of Phenylketonuria distinctly modulate gut nutrient absorption and bacterial growth – an in vitro study

苯丙酮尿症治疗中使用的蛋白质替代品显著调节肠道营养吸收和细菌生长——一项体外研究

2026-04-280
OAAI
Editorial: From nutrients; food matrices; bioactive compounds; to microbiota: exploring the path to optimal human health - Congress farm to fork: our food; our health; our future

社论:从营养素、食物基质、生物活性化合物到微生物组:探索实现最佳人类健康的路径——国会农场到餐桌:我们的食物;我们的健康;我们的未来

2025-11-210
OAAI
Biochemical and Anthropometric Outcomes in Paediatric Patients with Heterozygous Familial Hypercholesterolemia after COVID-19 Pandemic Lockdowns: An Exploratory Analysis

新型冠状病毒肺炎大流行封锁后杂合子家族性高胆固醇血症儿科患者的生化和人体测量结果: 探索性分析

2024-07-080
OAAI
Case report: Primary CDK4/6 inhibitor and endocrine therapy in locally advanced breast cancer and its effect on gut and intratumoral microbiota

病例报告: 局部晚期乳腺癌的主要CDK4/6抑制剂和内分泌治疗及其对肠道和肿瘤内微生物群的影响

2024-03-271
OAAI
Empowerment-based nutrition interventions on blood pressure: a randomized comparative effectiveness trial

基于赋权的营养干预对血压的影响:一项随机对照有效性试验

2023-11-130
OAAI
Intermittent energy restriction ameliorates adipose tissue-associated inflammation in adults with obesity: A randomised controlled trial
2022-08-0123
PRE
Vitamin D-related polymorphisms and vitamin D levels as risk biomarkers of COVID-19 disease severity

维生素d相关多态性和维生素d水平作为新型冠状病毒肺炎疾病严重程度的风险生物标志物

2021-10-2135
OAAI
Gut Microbiota Diversity and C-Reactive Protein Are Predictors of Disease Severity in COVID-19 Patients
2021-07-1963
OAAI